Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer

813.20
-3.25%
Motilal Oswal
Granules India (GRAN) delivered a slightly better-than-expected revenue in 4QFY25. However, it reported largely in-line EBITDA/PAT for the quarter.
Emkay released a Buy report for Granules India Ltd. with a price target of 950.0 on 03 Nov, 2026.
More from Granules India Ltd.
Recommended